Overview

Intravitreal Avastin in Proliferative Retinopathies

Status:
Completed
Trial end date:
2009-12-01
Target enrollment:
Participant gender:
Summary
The study intends to assess the effect of Avastin injections in different proliferative retinopathies due to different causes
Phase:
Phase 2
Details
Lead Sponsor:
Ophthalmological Association Edelweiss
Treatments:
Bevacizumab